The Ministry of Health and Prevention has made a historic achievement by coming to be the very first institution worldwide to use a smart application to help treat chronic or recurrent depression, or several depressive disorder, associated with multiple sclerosis (MS) for individuals over 18 years old. The application was introduced to offer social and psychological support to clients. The news was done throughout the Ministry's engagement at this year's Arab Health Event and Seminar in Dubai currently running till February 1, 2018.

Using artificial intelligence (AI), the DePrexis MS simulates replicates useful interventions based upon psychotherapy research study. International companies such as the United States Food and Drug Administration (FDA) and CE have accepted the use of app, which has been located to have the same favorable effects as medications according to the outcomes of several medical examinations involving more than 7,000 people. The outcomes were published in a variety of worldwide medical publications.

H.E Dr. Yousif Al Serkal, Assistant Undersecretary for Hospitals, said that the Ministry's latest success marks one more turning point in the UAE's method to offer AI-based clinical services. Growing financial investments in the most recent innovations and devices, boosting application of AI, and exploring sources in an imaginative method belong to this strategy.

H.E. said: "We are proud to be the first in the world to utilize this smart application to help treat anxiety connected with MS. It is terrific to utilize the current scientific technologies to alleviate the suffering of people. This is also part of the Ministry's method to advertise community health through stipulation of extensive, innovative, and first-rate health services to construct a satisfied society. The landmark will certainly additionally enhance our continuing campaigns to acquire leadership in the global health field, enhance local health solutions according to the best worldwide techniques, and obtain the highest possible score on the Global Competition Index in the field of health.

Dr. Kalthoum Al Baloushi, Director of Hospitals Administration, said: "The Ministry will always provide patient-focused medical care services. In this situation, we look for to minimize the suffering of MS individuals by assisting them smoothly incorporate right into society and supply social, emotional and support through sophisticated treatment techniques. These methods consist of the AI-based Deprexis MS application, the most up to date global restorative technique which we are using in the Ministry-run hospitals

Dr. Baloushi pointed out that MS is a persistent illness that influences the main nerve system, triggering the arms and legs to lose its toughness. It additionally brings about feeling numb or a feeling of light tingling in the limbs, difficulty in preserving equilibrium and focus, and obscured vision, among others. The condition usually influences youths in between 20 to 40 years old. Women are mostly affected by the disease compared to males. There are also some cases where children are diagnosed with MS.

"The leadership and efforts of the Ministry of Health and Preventionto innovate to help individuals with multiple sclerosis is absolutely commendable," stated Jean-Paul Scheuer, Nation Chair & General Manager, Sanofi Gulf Countries. "At Sanofi Genzyme, we have worked for over a decade to deliver scientific advancements that will certainly have a significant effect on the unmet demands of people coping with multiple sclerosis. We know that recognizing the experiences, challenges and even triumphs of those affected by it is a method ahead to dealing with the disorder. Innovation and modern technology play a important role in that."